These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23637928)

  • 1. 2009 A(H1N1) seroconversion rates and risk factors among the general population in Vientiane Capital, Laos.
    Kieffer A; Paboriboune P; Crépey P; Flaissier B; Souvong V; Steenkeste N; Salez N; Babin FX; Longuet C; Carrat F; Flahault A; de Lamballerie X
    PLoS One; 2013; 8(4):e61909. PubMed ID: 23637928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
    McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
    Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of individuals' risks to 2009 pandemic influenza virus infection at household level amongst Djibouti city residents--a CoPanFlu cross-sectional study.
    Andayi F; Crepey P; Kieffer A; Salez N; Abdo AA; Carrat F; Flahault A; de Lamballerie X
    Virol J; 2014 Jan; 11():13. PubMed ID: 24468218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.
    Tandale BV; Pawar SD; Gurav YK; Chadha MS; Koratkar SS; Shelke VN; Mishra AC
    BMC Infect Dis; 2010 Aug; 10():255. PubMed ID: 20738878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
    Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
    Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals.
    Kelly D; Burt K; Missaghi B; Barrett L; Keynan Y; Fowke K; Grant M
    BMC Immunol; 2012 Aug; 13():49. PubMed ID: 22937824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany.
    Cramer J; Mac T; Hogan B; Stauga S; Eberhardt S; Wichmann O; Mertens T; Burchard G
    Euro Surveill; 2012 Jan; 17(2):. PubMed ID: 22264864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccine.
    Zhou Y; Ng DM; Seto WH; Ip DK; Kwok HK; Ma ES; Ng S; Lau LL; Peiris JS; Cowling BJ
    PLoS One; 2011; 6(11):e27169. PubMed ID: 22102878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors.
    Azevedo LS; Gerhard J; Miraglia JL; Precioso AR; Tavares Timenetsky MD; Agena F; Gamba C; Shikanai Yasuda MA; David-Neto E; Pierrotti L
    Transpl Infect Dis; 2013 Dec; 15(6):612-8. PubMed ID: 24134688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
    Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
    Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with infection by 2009 pandemic H1N1 influenza virus during different phases of the epidemic.
    Chao DY; Cheng KF; Li TC; Wu TN; Chen CY; Tsai CA; Chen JH; Chiu HT; Lu JJ; Su MC; Liao YH; Chan WC; Hsieh YH;
    Int J Infect Dis; 2011 Oct; 15(10):e695-701. PubMed ID: 21767970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine.
    Sun Y; Bian C; Xu K; Hu W; Wang T; Cui J; Wu H; Ling Z; Ji Y; Lin G; Tian L; Zhou Y; Li B; Hu G; Yu N; An W; Pan R; Zhou P; Leng Q; Huang Z; Ma X; Sun B
    PLoS One; 2010 Dec; 5(12):e14270. PubMed ID: 21151563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.
    McVernon J; Laurie K; Faddy H; Irving D; Nolan T; Barr I; Kelso A
    Influenza Other Respir Viruses; 2014 Mar; 8(2):194-200. PubMed ID: 24382379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.
    Puleston RL; Bugg G; Hoschler K; Konje J; Thornton J; Stephenson I; Myles P; Enstone J; Augustine G; Davis Y; Zambon M; Nicholson KG; Nguyen-Van-Tam JS
    Health Technol Assess; 2010 Dec; 14(55):1-82. PubMed ID: 21208547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic.
    Skowronski DM; Hottes TS; Janjua NZ; Purych D; Sabaiduc S; Chan T; De Serres G; Gardy J; McElhaney JE; Patrick DM; Petric M
    CMAJ; 2010 Nov; 182(17):1851-6. PubMed ID: 20956500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal seroepidemiologic study of the 2009 pandemic influenza A (H1N1) infection among health care workers in a children's hospital.
    Yen TY; Lu CY; Chang LY; Tsai YT; Huang LM
    BMC Infect Dis; 2012 Apr; 12():89. PubMed ID: 22498010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.